{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T13:50:23Z","timestamp":1772286623674,"version":"3.50.1"},"reference-count":54,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T00:00:00Z","timestamp":1462924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology Research"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>Volume overload is common in liver cirrhosis, heart failure, and chronic kidney disease, being an independent risk factor for mortality. Loop diuretics have been widely used for treating volume overload in these patients. However, there is a tendency to increase the dose of loop diuretics partly because of diuresis resistance. Neurohormonal factors are also enhanced in these patients, which play a role in volume overload and organ ischemia. Loop diuretics cannot improve neurohormonal factors and could result in end\u2010organ damage. The water diuretic tolvaptan has been approved for use for volume overload in heart failure and liver cirrhosis. Despite causing similar increases in urine volume, its characteristics differ from those of loop diuretics. Renal blood flow is maintained with tolvaptan but decreased with furosemide in heart failure patients. Neurohormonal factors and blood pressure are not markedly altered by tolvaptan administration. It is expected that these mechanisms of tolvaptan can protect against worsening renal function by volume overload diseases compared with loop diuretics. It has also been reported that some patients do not respond well to tolvaptan. Loop diuretics and tolvaptan share the same mechanism with regard to decreasing renal interstitial osmolality, which plays a fundamental role in water diuresis. Thus, a high dose of loop diuretics could result in resistance to tolvaptan, so tolvaptan should be administered before increasing the loop diuretic dose. Therefore, volume control without enhancing end\u2010organ damage can be achieved by adding tolvaptan to a tolerable dose of Na\u2010sparing diuretics.<\/jats:p>","DOI":"10.1111\/hepr.12700","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T02:37:27Z","timestamp":1458355047000},"page":"11-22","source":"Crossref","is-referenced-by-count":29,"title":["Diuretic usage for protection against end\u2010organ damage in liver cirrhosis and heart failure"],"prefix":"10.1111","volume":"47","author":[{"given":"Takefumi","family":"Mori","sequence":"first","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine Tohoku University Graduate School of Medicine Sendai Japan"},{"name":"Division of Integrative Renal Replacement Therapy Tohoku University Graduate School of Medicine Sendai Japan"},{"name":"Division of Nephrology and Endocrinology Tohoku Medical and Pharmaceutical University Sendai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Ohsaki","sequence":"additional","affiliation":[{"name":"Division of Integrative Renal Replacement Therapy Tohoku University Graduate School of Medicine Sendai Japan"},{"name":"Division of Nephrology and Endocrinology Tohoku Medical and Pharmaceutical University Sendai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Oba\u2010Yabana","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine Tohoku University Graduate School of Medicine Sendai Japan"},{"name":"Division of Integrative Renal Replacement Therapy Tohoku University Graduate School of Medicine Sendai Japan"},{"name":"Division of Nephrology and Endocrinology Tohoku Medical and Pharmaceutical University Sendai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine Tohoku University Graduate School of Medicine Sendai Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,5,11]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199"},{"key":"e_1_2_11_3_1","first-page":"2387","article-title":"Management of hyponatremia","volume":"69","author":"Goh KP","year":"2004","journal-title":"Am Fam Physician"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.08.007"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.03.029"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2013.10.004"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199322003-00007"},{"key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","article-title":"OPC\u201041\u00a0061, a highly potent human vasopressin V2\u2010receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats","volume":"287","author":"Yamamura Y","year":"1998","journal-title":"J Pharmacol Exp Therapeut"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00195.2005"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-011-6304-x"},{"key":"e_1_2_11_11_1","first-page":"33","article-title":"Beneficial role of tolvaptan in the control of body fluids without reductions in residual renal function in patients undergoing peritoneal dialysis","volume":"29","author":"Mori T","year":"2013","journal-title":"Adv Perit Dial"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000168"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv010"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.2174\/157016111201140327163930"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00178.2014"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080532"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212163072511"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i41.11584"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005070757"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2011.05653.x"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2008.27"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FMJ05003X2"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0001-6772.2003.01206.x"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1997.273.1.R1"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.11.6.724"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1993.264.3.R578"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1992.72.1.231"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00701.2002"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00455.2014"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007121271"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.106.085811"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.111.965392"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00461.2001"},{"key":"e_1_2_11_34_1","first-page":"R568","article-title":"Functional and structural changes in the thick ascending limb of Henle's loop in rats with liver cirrhosis","volume":"273","author":"Jonassen TE","year":"1997","journal-title":"Am J Physiol"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199212000-00021"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2012.10.010"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/jp3069877"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.059139"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.215"},{"key":"e_1_2_11_40_1","first-page":"78","article-title":"The use of antagonists of vasopressin in studies of its physiological functions","volume":"44","author":"Sawyer WH","year":"1985","journal-title":"Fed Proc"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1992.tb09058.x"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-011-6349-x"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/0300060513480089"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205511"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12099"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12098"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12171"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23286"},{"key":"e_1_2_11_49_1","first-page":"R193","article-title":"Control of renal medullary blood flow by vasopressin V1 and V2 receptors","volume":"269","author":"Nakanishi K","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.32.5.896"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1161\/hy02t2.102908"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1159\/000381859"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-12-0971"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2009.07.004"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2014.219"}],"container-title":["Hepatology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhepr.12700","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhepr.12700","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hepr.12700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T21:16:05Z","timestamp":1748812565000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hepr.12700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1111\/hepr.12700"],"URL":"https:\/\/doi.org\/10.1111\/hepr.12700","archive":["Portico"],"relation":{},"ISSN":["1386-6346","1872-034X"],"issn-type":[{"value":"1386-6346","type":"print"},{"value":"1872-034X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,11]]}}}